PolyPeptide Group AG - Enterprise Value

The Enterprise Value as of August 2026 (TTM) for PolyPeptide Group AG (PPGN.SW) is 1.61B

According to PolyPeptide Group AG’s latest financial reports and current stock price. The company's current Enterprise Value is 1.61B. This represents a change of 70.41% compared to the average of 944.21M of the last 4 quarters.

PolyPeptide Group AG (PPGN.SW) Historical Enterprise Value (quarterly & annually)

How has PPGN.SW Enterprise Value performed in the past?

The mean historical Enterprise Value of PolyPeptide Group AG over the last ten years is 1.60B. The current 1.61B Enterprise Value has changed 9.96% with respect to the historical average. Over the past ten years (40 quarters), PPGN.SW's Enterprise Value was at its highest in in the December 2021 quarter at 4.26B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

PolyPeptide Group AG (PPGN.SW) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of PolyPeptide Group AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PolyPeptide Group AG (PPGN.SW) Average Enterprise Value

How has PPGN.SW Enterprise Value performed in the past?

The current Enterprise Value of PolyPeptide Group AG (PPGN.SW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

PolyPeptide Group AG (PPGN.SW) Enterprise Value vs. Peers

How is PPGN.SW’s Enterprise Value compared to its peers?

PolyPeptide Group AG’s Enterprise Value is less than Idorsia Ltd (2.81B), greater than Basilea Pharmaceutica AG (700.69M), greater than Cosmo Pharmaceuticals N.V. (1.11B), greater than Medartis Holding AG (1.22B), greater than SKAN Group AG (1.35B), less than Aevis Victoria S.A. (2.00B), greater than IVF Hartmann Holding AG (209.69M), greater than DocMorris AG (632.70M), greater than COLTENE Holding AG (335.11M), greater than Kuros Biosciences AG (897.75M),

Build a custom stock screener for PolyPeptide Group AG (PPGN.SW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PolyPeptide Group AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PolyPeptide Group AG (PPGN.SW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PolyPeptide Group AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.